ES395533A1 - Sustained released pharmaceutical compositions - Google Patents

Sustained released pharmaceutical compositions

Info

Publication number
ES395533A1
ES395533A1 ES395533A ES395533A ES395533A1 ES 395533 A1 ES395533 A1 ES 395533A1 ES 395533 A ES395533 A ES 395533A ES 395533 A ES395533 A ES 395533A ES 395533 A1 ES395533 A1 ES 395533A1
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
sustained released
released pharmaceutical
sustained
polysiloxane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES395533A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instituto de Angeli SpA
Original Assignee
Instituto de Angeli SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto de Angeli SpA filed Critical Instituto de Angeli SpA
Publication of ES395533A1 publication Critical patent/ES395533A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Abstract

A sustained release pharmaceutical composition comprising a solid matrix of acetylsalicylic acid or its pharmaceutically acceptable salts or complexes a polysiloxane and a water insoluble cellulose ether or ester.
ES395533A 1970-10-09 1971-09-29 Sustained released pharmaceutical compositions Expired ES395533A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4816770A GB1357737A (en) 1970-10-09 1970-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES395533A1 true ES395533A1 (en) 1974-10-16

Family

ID=10447626

Family Applications (1)

Application Number Title Priority Date Filing Date
ES395533A Expired ES395533A1 (en) 1970-10-09 1971-09-29 Sustained released pharmaceutical compositions

Country Status (8)

Country Link
US (1) US3853988A (en)
CA (1) CA974883A (en)
DE (1) DE2149699A1 (en)
DK (1) DK129434B (en)
ES (1) ES395533A1 (en)
FR (1) FR2110314B1 (en)
GB (1) GB1357737A (en)
SE (1) SE382560B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
DE2902414A1 (en) * 1979-01-23 1980-08-07 Hoechst Ag DEPOT BODY BASED ON SILICONE RUBBER AND METHOD FOR THE PRODUCTION THEREOF
FR2514261B1 (en) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog NOVEL COMPOSITION FOR COATING FOODS AND DRUGS AND GRANULES THUS COATED
DE3508097A1 (en) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt COMBINATION PRODUCT MADE OF XANTHINE DERIVATIVES AND O-ACETYLSALICYL ACID OR THEIR PHARMACOLOGICALLY COMPATIBLE SALTS AND THE USE THEREOF
FR2653338B1 (en) * 1989-10-23 1994-06-10 Dow Corning Sa FORMULATION FOR SUSTAINED RELEASE DRUGS AND THE USE THEREOF.
HUT75710A (en) * 1994-03-18 1997-05-28 Schmidt The use of dimeticone for the local antibacterial therapy and/or the prevention of helicobacter pylori (hp) associated syndromes and infectious diseases
DE4409357C2 (en) * 1994-03-18 1996-10-17 Upmeyer Hans Juergen Use of Dimeticon to eradicate Heliobacter pylori
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU6403196A (en) 1995-06-30 1997-02-05 Baylor University Polyester/carboxylic acid composite materials
US20110039807A1 (en) * 2009-08-13 2011-02-17 Kim Hyoung-Chun Anti-parkinsonian compound acetylsalicylic acid maltol ester
JP2015524395A (en) * 2012-07-17 2015-08-24 ダウ グローバル テクノロジーズ エルエルシー Composition comprising an organic liquid diluent and a very low viscosity cellulose ether

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
IL26885A (en) * 1965-12-06 1970-10-30 Smith Kline French Lab Pharmaceutical silicone compositions
US3518344A (en) * 1967-10-02 1970-06-30 Miles Lab Tableting lubricant

Also Published As

Publication number Publication date
GB1357737A (en) 1974-06-26
FR2110314B1 (en) 1975-06-06
SE382560B (en) 1976-02-09
DK129434C (en) 1975-03-10
DE2149699A1 (en) 1972-04-13
US3853988A (en) 1974-12-10
CA974883A (en) 1975-09-23
DK129434B (en) 1974-10-14
FR2110314A1 (en) 1972-06-02

Similar Documents

Publication Publication Date Title
ES403435A1 (en) Slow release pharmaceutical compositions
CA936472A (en) Formulation for sustained release of a biological agent
IL43839A0 (en) Compositions for sustained release of a medicament
ES395533A1 (en) Sustained released pharmaceutical compositions
AU3451371A (en) Improvements in or relating to pharmaceutical compositions
ZA713539B (en) Pharmaceutical compositions
MY7700200A (en) Pharmaceutical compositions
ES370058A1 (en) Antibiotic compositions
AU8251275A (en) Pharmaceutical compositions comprising 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid, and their uses
IL40685A0 (en) Pharmaceutical compositions for the dissolution of renal calculi and their preparation
IL37013A (en) Basically substituted alkylidene-aminooxyalkyl-carboxylic acid esters,their preparation and pharmaceutical compositions containing them
PH12292A (en) 7b-(d-5-amino-5-carboxyvaleramido)-7-methoxy-3-cephem 4-carboxylic acids and pharmacologically acceptable salts thereof and pharmaceutical compositions containing same
AU2441971A (en) Firefighting and compositions for use therein
IL36289A (en) Highly stable anaerobic compositions comprising acrylate ester monomer
GB1126153A (en) Novel polygalacturonic acid derivative
CA958643A (en) Pharmaceutical compositions containing cyclobenzaprine
IL37139A0 (en) Triakoxybenzoyl aminoalkanoic acid derivatives and pharmaceutical compositions containing them
ZA714785B (en) A pharmaceutical composition containing a pharmaceutically active compound
CA981583A (en) Pharmaceutical compositions containing dantrolene sodium
IE36108B1 (en) Pharmaceutical compositions
CA991653A (en) Sulphonic acid esters, their preparation, and their medicinal use
GB1287433A (en) Pharmaceutical compositions
CA843403A (en) Sustained release medicinal tablets
IL37623A0 (en) Theophylline isobutyrate salts,their preparation and pharmaceutical compositions containing them
AU456249B2 (en) Pharmaceutical compositions containing 4 hydroxynicotinic acid